The Future of Inflammation ResolutionIn this episode of Live Foreverish, Dr. Mike and Dr. Crystal welcome Harvard researcher Dr. Charles Serhan to discuss resolution medicine, a groundbreaking field focused on activating the body's natural inflammation-resolving mechanisms. Dr. Serhan explains how specialized pro-resolving mediators (SPMs), derived from omega-3 fatty acids like EPA and DHA, actively resolve inflammation rather than simply suppressing it. This show offers promising new strategies for treating chronic inflammatory diseases. #LELEARN #EDULFsocialGuest Bio: Prof. Charles Nicholas Serhan, PhD, DSc is the Simon Gelman Professor of Anaesthesia (Biochemistry and Molecular Pharmacology) at Harvard Medical School and Professor of Oral Medicine, Infection and Immunity at Harvard School of Dental Medicine. He is Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital. He has received several awards including an NIH MERIT award (2000) and has delivered over 50 keynote and plenary lectures. Among these, 2008 William Harvey Outstanding Scientist Medal and AAAS Fellow in 2011. In 2010, he received the Society for Leukocyte Biology Bonazinga Award for outstanding research on leukocytes, The American College of Rheumatology Hench (Nobel Laureate) Award Lecture in 2011 and is a Mérieux 2013 Laureate. In 2016, he received the IUBMB Lecture Medal and the Ross Prize in Molecular Medicine. In 2017, he received the International Eicosanoid Research Foundation’s Lifetime Achievement Award and the American Society of Investigative Pathology (ASIP) 2018 Rous Whipple Award.